Matthew Beyersdorf

Matthew Beyersdorf assists the Biotechnology Group in patent drafting, patent prosecution, due diligence support, IP portfolio management, and freedom-to-operate searching in the areas of molecular biology, cellular biology, drug development, and genetics.

Recent Posts

The Internet is Forever: Costs of Oversharing Online

Posted by Matthew Beyersdorf on May 23, 2019

Matthew Beyersdorf

A critical and early determinant in any procedural review is an examination of the permissibility of individual pieces of evidence. In matters of intellectual property, and particularly in IPRs, the permissibility of evidence often rests on two factors: whether a printed publication was publicly available and the relevant dates of that availability. As more and more companies disseminate disclosures and company information on the internet as a matter-of-course, the determination of both factors is becoming increasingly challenging to parse.

Read More

Topics: IPR, PTAB

Wolf Greenfield's Post-Grant Blog

Here, the Post-Grant Proceedings Group
at Wolf Greenfield keeps you up to date
on the latest decisions and best practices, and what they mean for you. Learn more about the group and its members.

New Call-to-action
New Call-to-action
New Call-to-action

Subscribe to Email Updates

Recent Posts

Follow Us

This blog is intended to promote thought and debate on developing areas of the law. The opinions, commentary and characterizations of cases provided on this blog are not legal advice and do not represent the opinions of Wolf Greenfield or its clients.